X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Panacea Biotech with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs GSK PHARMA - Comparison Results

PANACEA BIOTECH    Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH GSK PHARMA PANACEA BIOTECH/
GSK PHARMA
 
P/E (TTM) x 81.4 59.9 136.0% View Chart
P/BV x 1.8 11.7 15.4% View Chart
Dividend Yield % 0.0 2.1 -  

Financials

 PANACEA BIOTECH   GSK PHARMA
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-14
GSK PHARMA
Mar-16
PANACEA BIOTECH/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1493,850 3.9%   
Low Rs822,966 2.8%   
Sales per share (Unadj.) Rs84.1332.3 25.3%  
Earnings per share (Unadj.) Rs-18.344.3 -41.3%  
Cash flow per share (Unadj.) Rs-6.747.2 -14.2%  
Dividends per share (Unadj.) Rs050.00 0.0%  
Dividend yield (eoy) %01.5 0.0%  
Book value per share (Unadj.) Rs83.7202.7 41.3%  
Shares outstanding (eoy) m61.2584.70 72.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.410.3 13.4%   
Avg P/E ratio x-6.376.9 -8.2%  
P/CF ratio (eoy) x-17.272.2 -23.9%  
Price / Book Value ratio x1.416.8 8.2%  
Dividend payout %0112.9 0.0%   
Avg Mkt Cap Rs m7,074288,643 2.5%   
No. of employees `0002.84.6 59.6%   
Total wages/salary Rs m1,4494,434 32.7%   
Avg. sales/employee Rs Th1,874.16,104.5 30.7%   
Avg. wages/employee Rs Th527.0961.6 54.8%   
Avg. net profit/employee Rs Th-407.7813.7 -50.1%   
INCOME DATA
Net Sales Rs m5,15428,148 18.3%  
Other income Rs m1001,218 8.2%   
Total revenues Rs m5,25429,366 17.9%   
Gross profit Rs m-7664,774 -16.1%  
Depreciation Rs m711248 286.7%   
Interest Rs m1,5030-   
Profit before tax Rs m-2,8815,744 -50.1%   
Minority Interest Rs m110-   
Prior Period Items Rs m-60-   
Extraordinary Inc (Exp) Rs m1,77126 6,811.2%   
Tax Rs m172,018 0.8%   
Profit after tax Rs m-1,1213,752 -29.9%  
Gross profit margin %-14.917.0 -87.7%  
Effective tax rate %-0.635.1 -1.7%   
Net profit margin %-21.813.3 -163.2%  
BALANCE SHEET DATA
Current assets Rs m3,81021,462 17.8%   
Current liabilities Rs m8,36510,536 79.4%   
Net working cap to sales %-88.438.8 -227.7%  
Current ratio x0.52.0 22.4%  
Inventory Days Days15668 230.1%  
Debtors Days Days6716 409.5%  
Net fixed assets Rs m14,4804,717 307.0%   
Share capital Rs m61847 7.2%   
"Free" reserves Rs m90316,308 5.5%   
Net worth Rs m5,12717,171 29.9%   
Long term debt Rs m5,83216 36,448.1%   
Total assets Rs m19,43330,620 63.5%  
Interest coverage x-0.9NM-  
Debt to equity ratio x1.10 122,067.9%  
Sales to assets ratio x0.30.9 28.8%   
Return on assets %2.012.3 16.0%  
Return on equity %-21.921.9 -100.1%  
Return on capital %3.633.6 10.8%  
Exports to sales %24.50 172,562.5%   
Imports to sales %10.215.1 67.6%   
Exports (fob) Rs m1,2644 31,595.0%   
Imports (cif) Rs m5254,237 12.4%   
Fx inflow Rs m1,539519 296.6%   
Fx outflow Rs m9428,320 11.3%   
Net fx Rs m597-7,801 -7.7%   
CASH FLOW
From Operations Rs m5991,386 43.2%  
From Investments Rs m-4385,010 -8.7%  
From Financial Activity Rs m-303-6,383 4.7%  
Net Cashflow Rs m-14112 -1,197.5%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 0.6 10.2 5.9%  
FIIs % 1.3 23.8 5.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 15.4 153.2%  
Shareholders   10,259 102,036 10.1%  
Pledged promoter(s) holding % 35.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALKEM LABORATORIES  ELDER PHARMA  

Compare PANACEA BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Tata Stocks in Focus(09:30 am)

Asian stock indices are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.13% while the Hang Seng is down 0.54%. The Shanghai Composite is trading down by 0.02%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Aug 24, 2017 10:41 AM

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS